Anti–Interleukin-12 Antibody for Active Crohn's Disease von Mannon, Peter J, Fuss, Ivan J, Mayer, Lloyd, Elson, Charles O, Sandborn, William J, Present, Daniel, Dolin, Ben, Goodman, Nancy, Groden, Catherine, Hornung, Ronald L, Quezado, Martha, Neurath, Markus F, Salfeld, Jochen, Veldman, Geertruida M, Schwertschlag, Ullrich, Strober, Warren

Volltext

Randomized, controlled trial of recombinant human interleukin‐11 in patients with active Crohn's disease von Sands, B. E., Winston, B. D., Salzberg, B., Safdi, M., Barish, C., Wruble, L., Wilkins, R., Shapiro, M., Schwertschlag, U. S.

Volltext

Hematopoietic, immunomodulatory and epithelial effects of interleukin-11 von SCHWERTSCHLAG, U. S, TREPICCHIO, W. L, DYKSTRA, K. H, KEITH, J. C, TURNER, K. J, DORNER, A. J

Volltext

Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease von Sands, Bruce E., Bank ‡, Simmy, Sninsky §, Charles A., Robinson ∥, Malcolm, Katz ¶, Seymour, Singleton #, John W., Miner, Philip B., Safdi, Michael A., Galandiuk ‡‡, Susan, Hanauer §§, Stephen B., Varilek ∥∥, Gary W., Buchman ¶¶, Alan L., Rodgers ##, Vance D., Salzberg, Bruce, Cai ‡‡, Bin, Loewy ‡‡‡, John, DeBruin ‡‡‡, Michael F., Rogge ‡‡‡, Holly, Shapiro ‡‡‡, Mark, Schwertschlag ‡‡‡, Ullrich S.

Volltext

TD-1211 demonstrates tolerability and clinical activity following multiple treatment administration strategies in patients with opioid-induced constipation (OIC) von Singla, N, Canafax, D, Kang, A, Li, Y, Schwertschlag, U, Webster, L, Vickery, R

Volltext

TD-1211 demonstrates a durable increase in bowel movement frequency and return toward normal bowel function in a 5-week Ph2b Opioid-Induced Constipation (OIC) study von Vickery, R, Li, Y, Schwertschlag, U, Singla, N, Webster, L, Canafax, D

Volltext

No evidence of analgesic interference or CNS opioid withdrawal for TD-1211 in a phase 2b study in opioid-induced constipation (OIC) von Vickery, R, Webster, L, Li, Y, Schwertschlag, U, Singla, N, Canafax, D

Volltext

The Antiparasitic Moxidectin: Safety, Tolerability, and Pharmacokinetics in Humans von Cotreau, Monette M., Warren, Sarah, Ryan, John L., Fleckenstein, Lawrence, Vanapalli, Sreenivasa R., Brown, Kenneth R., Rock, David, Chen, Chieh-Yu, Schwertschlag, Ullrich S.

Volltext

Molecular Classification of Crohn's Disease and Ulcerative Colitis Patients Using Transcriptional Profiles in Peripheral Blood Mononuclear Cells von Burczynski, Michael E., Peterson, Ron L., Twine, Natalie C., Zuberek, Krystyna A., Brodeur, Brendan J., Casciotti, Lori, Maganti, Vasu, Reddy, Padma S., Strahs, Andrew, Immermann, Fred, Spinelli, Walter, Schwertschlag, Ulrich, Slager, Anna M., Cotreau, Monette M., Dorner, Andrew J.

Volltext

Mechanism and Amelioration of Recombinant Human Interleukin-11 (rhIL-11)-Induced Anemia in Healthy Subjects von Dykstra, Kevin H., Rogge, Holly, Stone, Anne, Loewy, John, Keith Jr, James C., Schwertschlag, Ullrich S.

Volltext

Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions von Trepicchio, W L, Ozawa, M, Walters, I B, Kikuchi, T, Gilleaudeau, P, Bliss, J L, Schwertschlag, U, Dorner, A J, Krueger, J G

Volltext

Platelet-activating factor-induced homologous and heterologous desensitization in cultured vascular smooth muscle cells von Schwertschlag, U S, Whorton, A R

Volltext

Analysis of Factors That Correlate With Mucositis in Recipients of Autologous and Allogeneic Stem-Cell Transplants von RAPOPORT, A. P, WATELET, L. F. M, ETTER, M. A, SPEAR, L, POWLEY, E, PACKMAN, C. H, ROWE, J. M, SCHWERTSCHLAG, U, BEDROSIAN, C, LIESVELD, J. L, LINDER, T, EBERLY, S, RAUBERTAS, R. F, LIPP, J, DUERST, R, ABBOUD, C. N, CONSTINE, L, ANDREWS, J

Volltext

Painful clitoral tumescence during bromocriptine therapy von Blin, O., Schwertschlag, U.S., Serratrice, G.

Volltext

Nonimmunological alterations of glomerular filtration by s-PAF in the rat kidney von Schwertschlag, Ullrich S., Dennis, Vincent W., Tucker, J. Allan, Camussi, Giovanni

Volltext

Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling von OESTREICHER, J. L, WALTERS, I. B, KIKUCHI, T, GILLEAUDEAU, P, SURETTE, J, SCHWERTSCHLAG, U, DORNER, A. J, KRUEGER, J. G, TREPICCHIO, W. L

Volltext

Phase 1 pharmacokinetic (PK) and pharmacodynamic(PD) evaluation of SF1126 a vascular targeted pan phosphoinositide 3- kinase (PI3K) inhibitor in patients with solid tumors von Schwertschlag, U. S., Chiorean, E. G., Anthony, S. P., Sweeney, C. J., Borad, M. J., Von Hoff, D. D., Garlich, J. R., Shelton, C. F., Ramanathan, R. K.

Volltext

K16 expression in uninvolved psoriatic skin: a possible marker of pre-clinical psoriasis von Bhawan, Jag, Bansal, Cheryl, Whren, Kara, Schwertschlag, Ullrich

Volltext

MITIGATING EFFECTS OF INTERLEUKIN 11 ON CONSECUTIVE COURSES OF 5-FLUOROURACIL-INDUCED ULCERATIVE MUCOSITIS IN HAMSTERS von Sonis, S.T., Van Vugt, A.G., McDonald, J., Dotoli, E., Schwertschlag, U., Szklut, P., Keith, J.

Volltext

The renin angiotensin aldosterone system and frusemide response in congestive heart failure von Reed, S, Greene, P, Ryan, T, Cerimele, B, Schwertschlag, U, Weinberger, M, Voelker, J

Volltext